Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 133-138

  Toikka, Jyri O ^a   Ahotupa, Markku ^b   Viikari, Jorma S A ^a   Niinikoski, Harri ^b   Taskinen, Marja Riitta ^c   Irjala, Kerttu ^a   Hartiala, Jaakko J ^a   Raitakari, Olli T ^a,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Endothelial function; High density lipoprotein; Oxidation

Indexed keywords

ALKADIENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; ARTERIOSCLEROSIS; BRACHIAL ARTERY; CHOLESTEROL, HDL; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; PROSPECTIVE STUDIES; VASODILATION;

EID: 0032853936     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00186-0     Document Type: Article

References (36)

1. Celermajer D.S Endothelial dysfunction: Does it matter? Is it reversible? J. Am. Coll. Cardiol. 30:1997;325.
2. Reddy K.G., Nair N.R., Sheehan H.M., Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J. Am. Coll. Cardiol. 23:1994;833.
3. Vita J.A., Treasure C.B., Nabel E.G. et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491.
4. Pitkänen O.-P., Raitakari O.T., Niinikoski H. et al. Coronary flow reserve is impaired in young men with hypercholesterolemia. J. Am. Coll. Cardiol. 28:1996;1705.
5. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24:1994;1468.
6. Stroes E.S.G., Koomans H.A., de Bruin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet. 346:1995;467.
7. Sorensen K.E., Celermajer D.S., Georgakopoulus D., Hatcher G., Betteridge D.J., Deanfield J.E. Impairment of endothelium-dependent dilatation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J. Clin. Invest. 93:1994;50.
8. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am. J. Med. 62:1977;707.
9. Barter P.J., Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis. 121:1996;1.
10. Matsuda Y., Hirata K., Inoue N., Suematsu M., Kawashima S., Akita H., Yokoyama M. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ. Res. 72:1993;1103.
11. Galle J., Öchslen M., Schollmeyer P., Wanner C. Oxidized lipoproteins inhibit endothelium-dependent vasodilation: effects of pressure and high-density lipoprotein. Hypertension. 23:1994;556.
12. Hessler J.R., Roberston A.L.J., Chisolm G.M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32:1979;213.
13. Parthasarathy S., Barnett J., Fong L.G. High density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044:1990;275.
14. Lapinleimu H., Viikari J., Jokinen E. et al. A prospective randomized trial in 1062 infants of a reduced saturated fat and cholesterol diet. Lancet. 345:1995;471.
15. Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111.
16. Joannides R., Haefeli W.E., Linder L., Richard V., Bakkali E.H., Thuillez C., Luscher T.F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314.
17. Sorensen K.E., Celermajer D.S., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Thomas O., Deanfield J.E. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br. Heart J. 74:1995;247.
18. Anderson T.J., Uehata A., Gerhard M.D. et al. Close relationship of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26:1995;1235.
19. Taskinen M.-R., Kuusi T., Helve E., Nikkilä E., Yki-Järvinen H. Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin dependent diabetes. Arteriosclerosis. 8:1988;168.
20. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499.
21. Ahotupa M., Ruutu M., Mäntylä E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin. Chem. 29:1996;139.
22. Tonstad S., Joakimsen O., Stensland-Bugge E., Leren T.P., Ose L., Russell D., Bonaa K.H. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler. Thromb. Vasc. Biol. 16:1996;984.
23. Ahotupa M., Marniemi J., Lehtimäki T. et al. Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin. Biochem. 31:1998;257.
24. SAS Institute Inc., SAS/STAT User's Guide. SAS Institute Inc., Cary, NC, 1988.
25. Zeiher A.M., Schächinger V., Hohnloser S.H., Saurbier B., Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 89:1994;2525.
26. Kuhn F.E., Mohler E.R., Satler L.F., Reagan K., Lu D.Y., Rackley C.E. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am. J. Cardiol. 68:1991;1425.
27. Raitakari O.T., Adams M.R., Celermajer D.S. Effect of lipoprotein(a) on the early functional and structural changes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 19:1999;990-995.
28. Heitzer T., Ylä-Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 93:1996;1346.
29. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89:1992;10.
30. Raitakari O.T., Pitkänen O.-P., Lehtimäki T. et al. In vivo LDL oxidation relates to coronary reactivity in young men. J. Am. Coll. Cardiol. 30:1997;97.
31. Watson A.D., Berliner J.A., Hama S.Y. et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882.
32. Zech R., Röckseisen M., Kluge K., Dewald K., Armstrong V.W., Chemnitius J.M. Lipoproteins and hydrolysis of organophosphorus compounds. Chem.-Biol. Interact. 87:1993;85.
33. Clarkson P., Celermajer D.S., Donald A.E. et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J. Am. Coll. Cardiol. 28:1996;573.
34. Adams M.R., Robinson J., McCredie R., Seale P.J., Sorensen K.E., Deanfield J.E., Celermajer D.S. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilatation in adults at risk of atherosclerosis. J. Am. Coll. Cardiol. 32:1998;123.
35. Raitakari O.T., Porkka K.V.K., Rönnemaa T., Knip M., Uhari M., Viikari J.S.A. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents: the cardiovascular risk in young Finns study. Diabetologia. 38:1995;1024.
36. Manninen V., Tenkanen L., Koskinen P., Huttunen J.K., Mänttäri M., Heinonen O.P., Frick M.H. Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study-implications for treatment. Circulation. 85:1992;37.